La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Chromocell Therapeutics Corp Com a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Chromocell Therapeutics Corp Com..

Chromocell Therapeutics Corp Com (AMEX:CHRO) Azioni, Catena delle Opzioni

Chromocell Therapeutics

Chromocell Therapeutics Corp Com

CHROMADEX CORP

CHROMOCURE INC by Chromocure, Inc.

Chromia - United States Dollar

Chronicle

Chrono.tech - United States Dollar

Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on ORIC Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIC#NASDAQ">ORIC</a>) with a Buy rating and announces Price Target of $15.

News

Price Target

Initiation

Analyst Ratings

ORIC

Ladenburg Thalmann Initiates Coverage On ORIC Pharmaceuticals with Buy Rating, Announces Price Target of $15

Trading Ideas

PROK

ProKidney Corp. Shares Halted On Circuit Breaker To The Upside, Stock Now Up 661.8%

WIIM

FLNC

Fluence Energy shares are trading higher after the company announced it was selected by AMPYR Australia for the Wellington battery project

Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on Cardiff Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDF#NASDAQ">CRDF</a>) with a Buy rating and announces Price Target of $19.

CRDF

Ladenburg Thalmann Initiates Coverage On Cardiff Oncology with Buy Rating, Announces Price Target of $19

Elon Musk has launched a new political venture—<a href="https://www.benzinga.com/news/politics/25/07/46265725/elon-musk-announces-formation-of-america-party-emerges-in-wake-of-donald-trumps-historic-spending-bill">the America Party</a>—with the kind of bravado only the world's richest man could muster. Frustrated by what he calls a "uniparty" system and spurred by a public fallout with President Donald Trump, Musk says he's here to give Americans a real alternative.
But while the announcement made waves on social media and stirred up headlines, the odds of this party becoming a lasting political force are slim to none, according to Grok, Musk&#8217;s own artificial intelligence (AI) chatbot.
For starters, <a href="https://www.benzinga.com/news/politics/25/07/46285761/can-elon-musk-run-for-president-or-even-be-speaker-of-the-house">the tech billionaire can't run for president</a>—he was born in South Africa, making him constitutionally ineligible. That alone makes it hard to rally a movement around a figure who can't top the ticket. Add to that the brutal reality of America's two-party system: third parties rarely gain traction, let alone win elections. Even with Musk's billions, building a viable party from scratch requires navigating 50 sets of ballot access laws, recruiting credible candidates and establishing a national infrastructure—none of which can be accomplished overnight.
<ul class="wp-block-list">
<li>Read More: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/07/46281860/elons-america-party-etf-a-what-if-fund-of-musk-linked-stocks-like-tesla-nvidia">Elon&#8217;s America Party ETF: A What-If Fund Of Musk-Linked Stocks Like Tesla, Nvidia</a></li>
</ul>
Then there's the charisma gap. Musk may be a tech visionary, but he's not exactly a political unifier. Polls show his favorability is underwater with most voters, and his appeal overlaps heavily with Trump's base—meaning he's more likely to split the right than build a new coalition. History is littered with failed third-party experiments, and unless something changes dramatically, the America Party looks destined to join them.
"It is more likely that the America Party will fail to achieve significant, lasting success than become a transformative force in U.S. politics. The structural barriers of the winner-takes-all electoral system, historical struggles of third parties, and Musk's polarizing persona make sustained success improbable," the AI bot said. "While short-term disruption, like winning a few congressional seats in 2026, is plausible due to Musk's resources and voter dissatisfaction, the America Party faces an uphill battle to overcome entrenched two-party dominance," it added.
<h2 class="wp-block-heading">10 Reasons Why The America Party May Fail</h2>
Here are 10 key reasons why Musk's Party, launched in July 2025, is unlikely to gain major traction or durability in U.S. politics, based on longstanding electoral dynamics and current political realities, according to Grok:
<ol class="wp-block-list">
<li>The Two-Party System Is Structurally Entrenched: The United States follows a winner-take-all format in single-representative districts, which significantly benefits the two dominant parties. Smaller political movements almost never secure seats, as their support can fragment the vote—effectively aiding either Democrats or Republicans. This setup has long suppressed outsider parties since the 1800s.</li>
<li>Third Parties Have Never Succeeded Before: No alternative party has remained nationally influential since the GOP&#8217;s birth in the mid-19th century. High-profile bids—such as Ross Perot's in 1992, which earned 19% of the vote but no electors, and Theodore Roosevelt's failed 1912 comeback—reinforce the historical hurdles.</li>
<li>Ballot Access Is A Legal Nightmare: Securing access to ballots involves navigating a patchwork of complicated state laws—requiring everything from extensive petition drives to procedural filings. Even with Musk's financial resources, managing a 50-state compliance operation is an enormous administrative and logistical burden.</li>
<li>Voting For A Third Party May Be Seen As A Waste: Voters often see non-major party support as ineffective in a binary system, prompting them to vote "against" rather than "for" a candidate. This behavior strongly disincentivizes support for new entrants like the America Party.</li>
<li>Musk's Divisive Public Image: Musk's approval rating dropped sharply—from 50% in late 2024 to 35% by mid-2025—due in part to provocative public comments. While some of his policies (e.g. DOGE) resonate, polling suggests that he himself remains a polarizing figure. Musk's political stances often shift rapidly—from backing Trump to attacking him, from pledging neutrality to launching a party. That volatility may undermine trust among voters and donors.</li>
<li>Public Feud With Trump: Musk's highly publicized disagreement with Trump—particularly over spending initiatives like the "Big Beautiful Bill"—has cost him support from Trump-aligned conservatives, potentially fracturing his potential voter coalition.</li>
<li>Vote-Splitting Consequences: By targeting voters disenchanted with the GOP, especially independent and male conservatives (Quantus Insights reports 57% openness among Republican men), Musk's movement could split that bloc—making it easier for Democrats to win narrowly contested races.</li>
<li>No Clear Ideological Identity: As of July 8, 2025, there has been no formal filing with the Federal Election Commission or a comprehensive policy platform. The absence of strategic direction—combined with Musk's track record of overpromising—raises doubts about long-term viability. Beyond fiscal hawkishness and anti-establishment rhetoric, the America Party lacks a coherent platform. Voters don't rally around vibes—they need vision. So far, the America Party's message is centered on Musk's personal grievances—especially fiscal policy and government "waste." Without a broader, coherent platform, it may fail to resonate beyond his fanbase.</li>
<li>Lack of On-the-Ground Mobilization: Establishing a serious political force requires grassroots engagement, field organizers, and state-level networks. So far, Musk seems to be relying on personal brand recognition and social media influence, which may not convert into real-world votes or turnout. There's no evidence of grassroots chapters, field offices, or candidate recruitment. A party without people on the ground is just a brand.</li>
<li>Conflicting Interests and Mixed Messaging: Critics, including Trump himself, have pointed out the contradiction between Musk's anti-government rhetoric and his companies' dependence on public contracts and subsidies (e.g. NASA partnerships, EV tax incentives). This contradiction could erode confidence among would-be supporters.</li>
</ol>
Taken together, these obstacles create a steep uphill climb for the America Party, making it unlikely to achieve nationwide relevance or electoral staying power in the current U.S. political system.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46286617/elon-musk-america-party-trump-republican-nightmare">8 Ways Elon Musk&#8217;s America Party Could Be Trump&#8217;s Worst Nightmare</a></li>
</ul>
Photo: Shutterstock

Politics

General

Elon Musk's America Party Already Looks Like A Flop: Grok

BofA Securities analyst Justin Post <a href="https://www.benzinga.com/quote/UBER/analyst-ratings" target="_blank" rel="noreferrer noopener">maintained a Buy</a> rating on Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and increased the price target from $97 to $115 on Tuesday.
Uber remains a top pick for 2025 for Post. The price boost reflects Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (once collectively known as FANG) multiple expansion, as per the analyst. However, the multiple is still a discount to FANG comps given Uber&#8217;s higher multiple on GAAP earnings.
Also Read: <a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/45843054/uber-wins-analyst-praise-for-robotaxi-boom-lyft-faces-tougher-road-ahead" target="_blank" rel="noreferrer noopener">Uber Wins Analyst Praise For Robotaxi Boom, Lyft Faces Tougher Road Ahead</a>
Post said optimism about Uber&#8217;s autonomous vehicle (AV) position can grow, given its AV partnerships globally — it is crossing 20, its proven ability to scale AVs with Waymo, signs of broader proliferation of L4 AV tech, strong booking growth, and Uber One traction suggesting subscriber lock-in.
The &#8220;No Tax on Tips&#8221; clause in the Big Beautiful Bill extends benefits to 1099 workers — not just W-2 employees — including gig workers like Uber and LYFT Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) drivers, the analyst highlighted. He said even those who don&#8217;t itemize deductions will be eligible for federal income tax savings, with a maximum deduction capped at $25,000.
Post estimated that U.S.-based Uber drivers will generate approximately $42 billion in earnings this year. If tips average 7% on an estimated $88 billion in U.S. gross bookings for 2025, the analyst projected that total tips would reach around $5.7 billion, or 14% of driver earnings. He estimated that an average federal tax rate of 18% implies about $1 billion in potential tax savings, equivalent to a 2.5% boost in driver pay.
Post expects the tax break to modestly increase driver supply, indirectly supporting Uber&#8217;s take rate.
According to Bloomberg, the analyst highlighted that Moove — an Uber-backed autonomous vehicle (AV) fleet manager — is raising $1.2 billion to support its partnership with Waymo, covering AVs that it plans to own and operate. While the initial rollout focuses on Phoenix and Miami, Post noted the scope could widen.
Moove remains a key partner in Uber&#8217;s AV ambitions, he said. Post sought clarity over whether Moove deploys these vehicles exclusively on Waymo&#8217;s platform or also on Uber&#8217;s. Regardless, this development reinforced his view that multiple AV suppliers will coexist long-term. A successful raise by Moove may also prompt other OEMs to accelerate investment in Level 4 automation, Post added.
Post projected fiscal 2025 sales of $50.7 billion and EPS of $3.04.
UBER Price Action:&nbsp;UBER stock is up 0.29% at $96.96 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46030504/uber-expands-ai-services-countries-businesses-train-smarter-ai-agents" target="_blank" rel="noreferrer noopener">Uber Collected Tons Of User Data For Years, Will License It To 30 Countries For AI</a></li>
</ul>
Photo: DenPhotos via Shutterstock.com

Analyst Color

Reiteration

AMZN

GOOG

GOOGL

LYFT

NFLX

UBER

Why Uber Could Keep Climbing: Tax Breaks, AV Partnerships, Strong Bookings Fuel Analyst Optimism

DGNX

Diginex shares are trading higher after the company proposed an 8-for-1 forward stock split.

ETON

Eton Pharmaceuticals shares are trading higher after the company announced the FDA has accepted its new drug application for ET-600.

Barclays analyst Terry Ma maintains American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) with a Equal-Weight and raises the price target from $249 to $297.

Barclays Maintains Equal-Weight on American Express, Raises Price Target to $297

Shares of Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) are moving higher Tuesday amid a complex mix of news involving potential U.S. export controls and newly announced tariffs on<a href="https://www.benzinga.com/markets/asia/25/07/46266218/us-plans-to-restrict-ai-chip-exports-to-malaysia-thailand-to-curb-diversion-to-china"> key Asian trading partners.</a>
What To Know: The Us Government is reportedly weighing restrictions on exports of AI chips to Malaysia and Thailand, a move aimed at blocking indirect access to advanced processors by China. Nvidia, a major supplier of AI chips, is expected to be affected by the draft rule from the Commerce Department, which targets countries seen as potential backdoor routes for Chinese companies. The rule is not final and could still be modified, but it signals a sharper stance on technology exports to Southeast Asia.
In a related development, President Donald Trump announced sweeping new tariffs as part of his renewed trade agenda, targeting imports from several nations including U.S. allies Japan and South Korea. A 25% tariff will apply to all goods from those two countries starting Aug. 1, unless trade negotiations succeed in reaching a resolution. Additional tariffs ranging from 25% to 40% were also introduced for countries like Malaysia, Thailand and others, according to Reuters.
Despite the headwinds for chipmakers tied to international sales and supply chains, AMD's stock held firm and rose, possibly reflecting investor confidence in the company's domestic positioning and product roadmap. It's also possible that some traders viewed the stock as relatively insulated from the immediate impact of export controls focused on Nvidia's high-end AI products.
AMD Price Action: Advanced Micro devices shares were up 2.72% at $138.47 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46296421/goldman-sachs-raises-sp500-forecast-6900">S&amp;P 500 Near 7,000? Inside Goldman&#8217;s New Gravity-Defying Forecast</a></li>
</ul>
Image Via Shutterstock.

Movers

AMD Stock Moves Higher Despite U.S. Chip Export Crackdown, Trump Tariff Escalation

Barclays analyst Terry Ma maintains Bread Finl Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>) with a Underweight and raises the price target from $45 to $52.

Barclays Maintains Underweight on Bread Finl Hldgs, Raises Price Target to $52

ARWR

Arrowhead Pharmaceuticals shares are trading higher after the company announced it has dosed the first patient for its YOSEMITE Phase 3 trial of RNAi-based Zodasiran.

Barclays analyst Terry Ma maintains SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Equal-Weight and raises the price target from $12 to $18.

SOFI

Barclays Maintains Equal-Weight on SoFi Technologies, Raises Price Target to $18

Barclays analyst Terry Ma maintains Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>) with a Overweight and raises the price target from $62 to $81.

Barclays Maintains Overweight on Synchrony Financial, Raises Price Target to $81

MRNA

Moderna shares are trading higher after the company announced it will sue RFK Jr over what they deem to be unlawful COVID-19 vaccine rollbacks.

Barclays analyst Jared Shaw maintains Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) with a Equal-Weight and raises the price target from $25 to $28.

Barclays Maintains Equal-Weight on Associated Banc, Raises Price Target to $28

SLNH

Soluna Holdings shares are trading higher after the company announced a 30 MW expansion with a bitcoin miner at its Dorothy 2 site.

Barclays analyst Jared Shaw maintains Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) with a Overweight and raises the price target from $18 to $19.

BANC

Barclays Maintains Overweight on Banc of California, Raises Price Target to $19

Barclays analyst Jared Shaw maintains Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) with a Underweight and raises the price target from $67 to $68.

Barclays Maintains Underweight on Bank of Hawaii, Raises Price Target to $68

Barclays analyst Jared Shaw maintains BankUnited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKU#NYSE">BKU</a>) with a Equal-Weight and raises the price target from $38 to $41.

Barclays Maintains Equal-Weight on BankUnited, Raises Price Target to $41

Health Care

Press Releases

Chromocell to Present at Upcoming Fall Investor Conferences

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

Chromocell Announces Name Change to "Channel Therapeutics Corporation" and Provides Therapeutic Program Updates

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models

Financing

Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

Comments

Chromocell Therapeutics Corp Com

Chromocell Therapeutics Corp Com (CHRO) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO